NEW YORK, March 22 (GenomeWeb News) - Inpharmatica has made its ADME (absorption, distribution, metabolism, and excretion) technology available to GlaxoSmithKline, the company said today.

 

Under the agreement, Inpharmatica, based in London, will apply its ADME technology to a number of GSK's drug discovery programs in the UK and in Europe.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.